文献速递分子诊断临床微生物

PCR/电喷雾电离质谱检测疑似脓毒症患者全血血流微生物的性能

Performance of PCR/Electrospray Ionization-Mass Spectrometry on Whole Blood for Detection of Bloodstream Microorganisms in Patients with Suspected Sepsis.
PubMed 文献 · J Clin Microbiol · 2020-08-24

该多中心研究评估PCR/电喷雾电离质谱(PCR/ESI-MS)检测全血血流微生物的性能,在2,754份模拟全血样本中真阳性率99.1%、真阴性率97.2%;在1,460例疑似脓毒症患者中,PCR/ESI-MS阳性率25.6%高于血培养的14.6%,对革兰阴性菌和念珠菌敏感性较高,抗菌治疗前阳性率更高。

要点

  • PCR/ESI-MS在模拟全血样本中性能优异,真阳性率99.1%,真阴性率97.2%。
  • 疑似脓毒症患者中PCR/ESI-MS阳性率25.6%,高于血培养的14.6%。
  • 对革兰阴性菌和念珠菌敏感性分别为78%和83%,所有菌种特异性>94%。

核心结论

  • PCR/ESI-MS在模拟样本中性能优异,临床样本中特异性高,对革兰阴性菌和念珠菌敏感性中等偏高,抗菌治疗期间阳性率升高。

研究设计与样本

  • 多中心研究,纳入美国13家和欧洲3家教学医院,共16家;评估2,754份模拟全血样本和1,460例疑似脓毒症患者(sepsis-2定义)。

主要发现

  • 模拟全血样本中PCR/ESI-MS真阳性率99.1%,真阴性率97.2%。
  • 疑似脓毒症患者中血培养和PCR/ESI-MS阳性率分别为14.6%和25.6%。
  • 结果组合:血培养阳性/PCR/ESI-MS阴性4.3%,两者均阳性10.3%,血培养阴性/PCR/ESI-MS阳性15.3%,两者均阴性70.1%。
  • 与血培养相比,PCR/ESI-MS敏感性(不含凝固酶阴性葡萄球菌):革兰阳性菌58%,革兰阴性菌78%,念珠菌属83%。
  • 所有单个菌种特异性均>94%。

关键数值与推荐

  • 模拟全血样本真阳性率99.1%,真阴性率97.2%。
  • 疑似脓毒症患者血培养阳性率14.6%,PCR/ESI-MS阳性率25.6%。
  • PCR/ESI-MS敏感性:革兰阳性菌58%,革兰阴性菌78%,念珠菌属83%(不含凝固酶阴性葡萄球菌)。
  • 所有单个菌种特异性>94%。
  • 既往抗菌治疗患者PCR/ESI-MS阳性率31% vs 未治疗患者22%(P<0.0001)。

临床怎么用

  • PCR/ESI-MS可作为脓毒症血流微生物检测的补充手段,尤其对革兰阴性菌和念珠菌。
  • 抗菌治疗期间PCR/ESI-MS阳性率更高,可能有助于已用药患者的病原检测。

局限性

  • 对革兰阳性菌敏感性中等(58%),不含凝固酶阴性葡萄球菌。
  • 研究未报告其他性能参数或临床影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Blood culture (BC) often fails to detect bloodstream microorganisms in sepsis. However, molecular diagnostics hold great potential. The molecular method PCR/electrospray ionization-mass spectrometry (PCR/ESI-MS) can detect DNA from hundreds of different microorganisms in whole blood. The aim of the present study was to evaluate the performance of this method in a multicenter study including 16 teaching hospitals in the United States (n = 13) and Europe (n = 3). First, on testing of 2,754 contrived whole blood samples, with or without spiked microorganisms, PCR/ESI-MS produced 99.1% true-positive and 97.2% true-negative results. Second, among 1,460 patients with suspected sepsis (sepsis-2 definition), BC and PCR/ESI-MS on whole blood were positive in 14.6% and 25.6% of cases, respectively, with the following result combinations: BC positive and PCR/ESI-MS negative, 4.3%; BC positive and PCR/ESI-MS positive, 10.3%; BC negative and PCR/ESI-MS positive, 15.3%; and BC negative and PCR/ESI-MS negative, 70.1%. Compared with BC, PCR/ESI-MS showed the following sensitivities (coagulase-negative staphylococci not included): Gram-positive bacteria, 58%; Gram-negative bacteria, 78%; and Candida species, 83%. The specificities were >94% for all individual species. Patients who had received prior antimicrobial medications (n = 603) had significantly higher PCR/ESI-MS positivity rates than patients without prior antimicrobial treatment-31% versus 22% (P < 0.0001)-with pronounced differences for Gram-negative bacteria and Candida species. In conclusion, PCR/ESI-MS showed excellent performance on contrived samples. On clinical samples, it showed high specificities, moderately high sensitivities for Gram-negative bacteria and Candida species, and elevated positivity rates during antimicrobial treatment. These promising results encourage further development of molecular diagnostics to be used with whole blood for detection of bloodstream microorganisms in sepsis.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Strålin K, Rothman RE, Özenci V, et al. Performance of PCR/Electrospray Ionization-Mass Spectrometry on Whole Blood for Detection of Bloodstream Microorganisms in Patients with Suspected Sepsis. J Clin Microbiol. 2020. PMID: 32641399. doi:10.1128/JCM.01860-19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。